Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Renaissance is a leading Chinese financial institution that provides investment banking and investment management services, with a specialized focus on the healthcare and life sciences sectors. The firm offers a comprehensive suite of services including private placement advisory, M&A, underwriting, and asset management through its Huaxing Growth Capital arm. It has been instrumental in the growth of the Chinese biotech ecosystem, advising on and investing in numerous high-profile healthcare IPOs and funding rounds. Headquartered in Beijing, the group operates globally with a presence in major financial hubs including Hong Kong, Shanghai, and New York.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Renaissance Group.